Literature DB >> 32333867

Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?

Angelo Avogaro1, Gian Paolo Fadini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32333867     DOI： 10.1016/S2213-8587(20)30044-9

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  3 in total

1.  Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies.

Authors:  Gian Paolo Fadini; Olga Disoteo; Riccardo Candido; Paolo Di Bartolo; Luigi Laviola; Agostino Consoli
Journal:  Diabetes Ther       Date:  2021-02-07       Impact factor: 2.945

2.  Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study.

Authors:  Enrico Longato; Barbara Di Camillo; Giovanni Sparacino; Lara Tramontan; Angelo Avogaro; Gian Paolo Fadini
Journal:  Cardiovasc Diabetol       Date:  2021-11-13       Impact factor: 9.951

3.  Why diabetes outpatient clinics should not close during pandemic crises.

Authors:  G P Fadini; B M Bonora; M L Morieri; A Avogaro
Journal:  J Endocrinol Invest       Date:  2021-01-04       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.